Syros Pharmaceuticals: Rising Despite Dilution, A Must Look (NASDAQ:SYRS)


3d illustration of the strong increase of non-functional white blood cells called leukemia cells leading to blood cancer disease

Christoph Burgstedt/iStock via Getty Images

Topline Summary

Syros Pharmaceuticals (NASDAQ:SYRS) is a cancer-focused developmental biotech working on novel therapies for different forms of blood cancer. They currently have one main drug in development, for which they have encouraging data and


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *